Solid Tumor Panel NGS Genetic DNA Test
Comprehensive Cancer Genetic Analysis
The Solid Tumor Panel NGS Genetic DNA Test represents a groundbreaking advancement in cancer diagnostics, utilizing cutting-edge next-generation sequencing (NGS) technology to provide comprehensive genetic profiling of solid tumors. This sophisticated test examines over 150 cancer-related genes simultaneously, offering unprecedented insights into the molecular landscape of various malignancies.
What This Test Measures and Detects
This comprehensive panel analyzes genetic mutations, alterations, and variations across a wide spectrum of cancer-associated genes including:
- Oncogenes such as BRAF, KRAS, NRAS, and EGFR
- Tumor suppressor genes including TP53, BRCA1, BRCA2, and PTEN
- DNA repair genes like ATM, CHEK2, and PALB2
- Growth factor receptors including ERBB2 (HER2) and MET
- Cell cycle regulators such as CDKN2A and RB1
- Epigenetic modifiers including EZH2 and DNMT3A
Who Should Consider This Test
This advanced genetic testing is particularly beneficial for individuals experiencing:
- Newly diagnosed solid tumors requiring comprehensive genetic profiling
- Recurrent or metastatic cancer seeking targeted therapy options
- Family history of multiple cancers suggesting hereditary cancer syndromes
- Unusual cancer presentations or early-onset malignancies
- Resistance to standard cancer treatments requiring alternative approaches
- Multiple primary cancers in the same individual
Key Benefits of Solid Tumor Panel Testing
- Personalized Treatment Planning: Identifies specific genetic alterations that may respond to targeted therapies
- Comprehensive Analysis: Simultaneously examines 150+ cancer-related genes in a single test
- Clinical Trial Matching: Helps identify potential eligibility for precision medicine clinical trials
- Prognostic Information: Provides insights into cancer behavior and potential treatment responses
- Hereditary Risk Assessment: Detects inherited cancer predisposition mutations
- Treatment Monitoring: Can track genetic changes over time to guide therapy adjustments
Understanding Your Test Results
Your test results will provide detailed information about:
- Pathogenic Mutations: Genetic changes known to contribute to cancer development
- Variants of Uncertain Significance (VUS): Genetic changes with unknown clinical impact
- Actionable Findings: Mutations with available targeted therapies or clinical implications
- Germline vs. Somatic Variants: Distinguishes between inherited and acquired mutations
All results should be interpreted by a qualified oncologist or genetic counselor who can explain the clinical significance and recommend appropriate next steps based on your specific genetic findings.
Test Pricing Information
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Solid Tumor Panel NGS Genetic DNA Test | $500 USD | $750 USD |
Nationwide Testing Availability
We have testing facilities conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and oncology specialists ensures you receive comprehensive support throughout the testing process.
Take Control of Your Cancer Journey
Don’t leave your cancer treatment to chance. The Solid Tumor Panel NGS Genetic DNA Test provides the critical genetic information needed to make informed decisions about your cancer care. With results available in just 3-4 weeks and multiple sample collection options (blood, extracted DNA, or FTA card), getting this comprehensive genetic analysis has never been more accessible.
Ready to unlock the power of precision medicine? Book your Solid Tumor Panel NGS Genetic DNA Test today by calling our dedicated genetics team at +1(267) 388-9828 or schedule your appointment online. Take the first step toward personalized cancer care and discover treatment options tailored to your unique genetic profile.
